3816 results for «222»

Filter By

3816 results

OCT and artificial intelligence: a new shiny light for better decision making in complex coronary interventions

15 Dec 2022 – From GulfPCR-GIM 2022

Watch this case-in-point presentation focusing on decision-making in complex PCI using OCT plus AI to understand how to take the right measurement throughout the procedure, how artificial intelligence aids in decision making during imaging-guided PCI, and to gain skills in interpreting OCT imaging, among others!

OCT and artificial intelligence: a new shiny light for better decision making in complex coronary interventions

Tricuspid regurgitation: a new prospect in the management of patients with TR

15 Dec 2022 – From GulfPCR-GIM 2022

Thanks to this GulfPCR-GIM 2022 session, get to understand how the TricValve can help in the management of patients with functional TR, know more about the TricValve Bicaval Valves system, and gain insight into the early adoption experience in the Middle East.

Tricuspid regurgitation : a new prospect in the management of patients with TR

Optimising immediate and long-term outcomes after TAVI

15 Dec 2022 – From GulfPCR-GIM 2022

This session focuses on the use of the Acurate Neo2 valve in daily practice: watch it if you wish to learn how to determine clinical scenarios where the valve in question would be the best option, to find out more about lifetime management of AS patients...

Optimising immediate and long-term outcomes after TAVI

Another frontier crossed!

15 Dec 2022 – From GulfPCR-GIM 2022

Watch this session to find out more about the optimal approach to complex patients, to learn about optimal plaque modification techniques, including atherectomy, to discuss the approach to severely calcified lesions, and to know more about the added value of intravascular imaging.

Another frontier crossed!

Managing a high bleeding risk patient undergoing PCI

15 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, analyse the cases of a 76-year-old female patient with asthma, angina on exertion, multiple calcific tandem lesions in the LAD and LCX, and minimal RCA disease, and of a 48-year-old male patient, smoker, with ACS in 2012 and 2020, who presented with...

Managing a high bleeding risk patient undergoing PCI

TAVI in 2022 - Lifetime management, durability and clinical relevance to patients

14 Dec 2022 – From GulfPCR-GIM 2022

In this session, a panel of experts address important issues on TAVR, especially regarding younger patients. Join them as they discuss lifetime management, valve durability, and the latest devices' role in extending re-intervention timelines.

TAVI in 2022 - Lifetime management, durability and clinical relevance to patients

Stable CAD - Tools, devices and techniques

14 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, 3 cases of stent loss are presented, as well as a remote robotic DK Crush in a 3D printed anatomy, and an onion-shaped stent layer in an in-stent restenosis patient.

Stable CAD - Tools, devices and techniques

Challenging CTO Cases - Session 1

14 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, learn about a complex challenging case of left main bifurcation disease and ostial left anterior descending CTO, as well as a rotational atherectomy assisted-PCI for an old calcified CTO, and more!

Challenging CTO Cases - Session 1

Challenging TAVI scenarios

14 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session is for you if you want to learn more about recurrent valve migration during TAVR or TAVI with permanent pacemaker implantation, among others!

Challenging TAVI scenarios

Challenging CTO cases - Session 2

14 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session compiles 5 challenging CTO cases and explains how to handle them. Study for example a flush ostial RCA-CTO, PWS in a CTO feeding vessel, rotablation and intravascular lithotripsy in three-vessel disease with IVUS, or rotaburr incarceration.

Challenging CTO cases - Session 2

The why and how of performing a successful TAVI case

14 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, observe a 72-year-old male patient with NYHA class II exertional dyspnoea, CAD status after revascularisation, type II DM, CKD IIIB, recently admitted for decompensated HF and type II NSTEMI, who was referred to the clinic for aortic valve replacement.

The why and how of performing a successful TAVI case

Challenging ACS scenarios

14 Dec 2022 – From GulfPCR-GIM 2022

Topics in this GulfPCR-GIM 2022 session include the role of imaging in an unusual case of ACS in a young patient, PCI of an abnormal left coronary artery with AMI, embolisation of a thrombus in a non-culprit vessel during PCI in a late-presenting anterior STEMI, and...

Challenging ACS scenarios

PCI in stable CAD

14 Dec 2022 – From GulfPCR-GIM 2022

Study the two cases presented in this GulfPCR-GIM 2022 session to find out more about the importance of proper monitoring in detecting post-PCI complications and managing complex PCI and coronary stent loss.

PCI in stable CAD

Primary mitral regurgitation: treatment options when the anatomy is simple

27 Nov 2022 – From PCR London Valves 2022

Consult this session to learn about the different technical aspects and limitations for both surgical and catheter-based techniques and to understand the design and implications of two current RCTs comparing interventional and surgical techniques in patients with primary mitral regurgitation.

Primary mitral regurgitation: treatment options when the anatomy is simple

Tricuspid and pulmonary interventions

27 Nov 2022 – From PCR London Valves 2022

Watch this series of cases presented at PCR LV 2022 and learn more about Alagille syndrome, how to treat a significant right-to-left shunt after bicaval valve implantation, or analyze transcatheter pulmonary valve implantation in tetralogy of Fallot, among others.

Tricuspid and pulmonary interventions

TAVI: Late-Breaking Trials and Innovations

27 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions, and learn more about the early safety and performance of the Vienna TAVI system, the new-generation transcatheter aortic valve platforms performance in native pure aortic regurgitation, and more!

TAVI: Late-Breaking Trials and Innovations

Imaging for tricuspid valve interventions: anatomical assessment, grading of severity and peri-procedural guidance

27 Nov 2022 – From PCR London Valves 2022

Consult these presentations on imaging for tricuspid valve interventions to learn more about how to adequately assess tricuspid valve anatomy and identify which criteria determine procedure-related prognosis, how to determine the severity of tricuspid regurgitation and identify key pitfalls in assessment, as well as how to guide a...

Imaging for tricuspid valve interventions: anatomical assessment, grading of severity and peri-procedural guidance

Rapid-fire abstracts: session 4

27 Nov 2022 – From PCR London Valves 2022

In this PCR LV 2022 session dedicated to TAVI, take advantage of the 7 abstracts to learn more about the impact of TAVI for pure regurgitation on the severity of concomitant mitral regurgitation, the deformation of transcatheter heart valve and haemodynamics after aortic ViV, and much...

Rapid-fire abstracts: session 4

Transcatheter primary mitral regurgitation repair and tricuspid replacement - LIVE case

28 Nov 2022 – From PCR London Valves 2022

  • Part 1: Primary MR repair (recorded case)
    An 89-year-old male with atrial fibrillation, severe primary MR (prolapse A1-A2) with a preserved LV function. The operators implant 1 Pascal ACE, on general anaesthesia, guided by TEE.
  • Part 2: Tricuspid valve in valve (Live case)
    A 52-year-old female, with diabetes and...
Transcatheter intervention for mitral and tricuspid valve disease: state of the art

Is frailty still relevant after 20 years of TAVI?

28 Nov 2022 – From PCR London Valves 2022

Consult this session to gain further knowledge of the frailty syndrome, to understand its relevance in today's patient population and to learn how to measure it using validated tools.

Is frailty still relevant after 20 years of TAVI?
Didn’t find what you were looking for?